LAUSR

About LAUSR
Donate
Contact Us

Follow us:

You are not signed in:

Sign Up!


   Articles with "everolimus eluting" as a keyword



Photo by nci from unsplash

Everolimus eluting bioresorbable vascular scaffolds; can we absorb the risk in complex PCI?

Sign Up to like & get
recommendations! Published in 2017 at "Catheterization and Cardiovascular Interventions"

DOI: 10.1002/ccd.27165

Abstract: Key Points BVS, as compared with DES, have higher stent thrombosis (ST) rates. BVS may prove reasonable in patients with complex anatomy. Future trials will be necessary to guide clinicians regarding whether BVS are equivalent… read more here.

Keywords: vascular scaffolds; anatomy; everolimus eluting; eluting bioresorbable ... See more keywords
Photo from wikipedia

Bioresorbable vascular scaffold versus everolimus‐eluting stents or drug eluting balloon for the treatment of coronary in‐stent restenosis: 1‐Year follow‐up of a propensity score matching comparison (the BIORESOLVE‐ISR Study)

Sign Up to like & get
recommendations! Published in 2018 at "Catheterization and Cardiovascular Interventions"

DOI: 10.1002/ccd.27473

Abstract: to compare the 1‐year outcome between bioresorbable vascular scaffold (BVS), everolimus‐eluting stent (EES), and drug‐eluting balloon (DEB) for in‐stent restenosis (ISR) treatment. read more here.

Keywords: drug eluting; vascular scaffold; stent restenosis; eluting balloon ... See more keywords
Photo from wikipedia

Comparison of neointimal coverage between durable‐polymer everolimus‐eluting stents and bioresorbable‐polymer everolimus‐eluting stents 1 year after implantation using high‐resolution coronary angioscopy

Sign Up to like & get
recommendations! Published in 2019 at "Catheterization and Cardiovascular Interventions"

DOI: 10.1002/ccd.28095

Abstract: We aimed to compare the coronary angioscopic appearance of neointimal coverage (NIC) over durable‐polymer everolimus‐eluting stents (XIENCE‐EES) and bioresorbable‐polymer everolimus‐eluting stents (SYNERGY‐EES) 1 year after implantation. read more here.

Keywords: polymer everolimus; eluting stents; everolimus eluting; neointimal coverage ... See more keywords
Photo from wikipedia

Angiographic performance of everolimus‐eluting stents for the treatment of coronary in‐stent restenosis in daily practice

Sign Up to like & get
recommendations! Published in 2020 at "Catheterization and Cardiovascular Interventions"

DOI: 10.1002/ccd.29225

Abstract: The present study aims to analyze the angiographic anti‐restenotic performance of durable polymer everolimus‐eluting stents (EES) for the treatment of in‐stent restenosis (ISR) in daily practice. read more here.

Keywords: eluting stents; stent restenosis; performance; everolimus eluting ... See more keywords
Photo by nci from unsplash

Diabetes and everolimus eluting bioresorbable poly‐L‐lactide vascular scaffolds for coronary artery disease: Dead‐end or some path forward?

Sign Up to like & get
recommendations! Published in 2021 at "Catheterization and Cardiovascular Interventions"

DOI: 10.1002/ccd.29900

Abstract: • Bioresorbable vascular scaffolds (BVS) intend to overcome long-term limitations of permanent metallic coronary stent implants, particularly in the proinflammatory, prothrombotic diabetic milieu. • The Amsterdam Investigator-Initiated Absorb Strategy All-Comers (AIDA) trial demonstrates worse 3year… read more here.

Keywords: diabetes everolimus; poly lactide; everolimus eluting; eluting bioresorbable ... See more keywords
Photo from wikipedia

Everolimus-eluting bioresorbable vascular scaffold in daily clinical practice: A single-centre experience

Sign Up to like & get
recommendations! Published in 2017 at "Netherlands Heart Journal"

DOI: 10.1007/s12471-017-1038-4

Abstract: BackgroundRecent evidence has raised concerns regarding the safety of the everolimus-eluting bioresorbable vascular scaffold (E-BVS) (Absorb, Abbott Vascular, Santa Clara, CA, USA). Following these data, the use of this device has diminished in the Netherlands;… read more here.

Keywords: vascular scaffold; centre; practice; everolimus eluting ... See more keywords
Photo by goian from unsplash

Five-year clinical outcomes of everolimus-eluting stents from the post marketing study of CoCr-EES (XIENCE V/PROMUS) in Japan

Sign Up to like & get
recommendations! Published in 2018 at "Cardiovascular Intervention and Therapeutics"

DOI: 10.1007/s12928-018-0515-z

Abstract: The Cobalt Chromium Everolimus-Eluting Stent (CoCr-EES) Post Marketing Surveillance (PMS) Japan study is a prospective multicenter registry designed to evaluate the safety and efficacy of XIENCE V/PROMUS everolimus-eluting stents in routine clinical practice at 47… read more here.

Keywords: cocr ees; clinical outcomes; year; japan ... See more keywords
Photo by papaioannou_kostas from unsplash

Coronary risk factors associated with OCT macrophage images and their response after CoCr everolimus-eluting stent implantation in patients with stable coronary artery disease.

Sign Up to like & get
recommendations! Published in 2017 at "Atherosclerosis"

DOI: 10.1016/j.atherosclerosis.2017.08.002

Abstract: BACKGROUND AND AIMS The aim of this study was to evaluate the accumulation of optical coherence tomography (OCT)-macrophages and OCT findings after CoCr everolimus-eluting stent placement, in addition to coronary risk factors. METHODS A total… read more here.

Keywords: cocr everolimus; high macrophage; group; everolimus eluting ... See more keywords
Photo by nci from unsplash

Everolimus-Eluting Bioresorbable Scaffolds Versus Everolimus-Eluting Metallic Stents.

Sign Up to like & get
recommendations! Published in 2017 at "Journal of the American College of Cardiology"

DOI: 10.1016/j.jacc.2017.04.011

Abstract: BACKGROUND Recent evidence suggests that bioresorbable vascular scaffolds (BVS) are associated with an excess of thrombotic complications compared with metallic everolimus-eluting stents (EES). OBJECTIVES This study sought to investigate the comparative effectiveness of the Food and Drug… read more here.

Keywords: risk; compared metallic; metallic ees; bioresorbable scaffolds ... See more keywords
Photo by nci from unsplash

TCT-651 Coronary Risk Factors Associated with OCT Macrophage Images and their Response After CoCr Everolimus-Eluting Stent Implantation in Patients with Stable Coronary Artery Disease: Subanalysis of the MECHANISM-Elective study

Sign Up to like & get
recommendations! Published in 2017 at "Journal of the American College of Cardiology"

DOI: 10.1016/j.jacc.2017.09.899

Abstract: The purpose of this study was to evaluate the accumulation of optical coherence tomography (OCT)-macrophages and OCT findings after CoCr everolimus-eluting stent placement, in addition to coronary risk factors. A total of 89 lesions in… read more here.

Keywords: cocr everolimus; risk factors; study; coronary risk ... See more keywords

TCTAP C-208 Appearance of Peri-stent Contrast Staining in Everolimus Eluting Stent After Target Vessel Revascularization

Sign Up to like & get
recommendations! Published in 2019 at "Journal of the American College of Cardiology"

DOI: 10.1016/j.jacc.2019.03.415

Abstract: ### Patient Initials or Identifier Number T.T ### Relevant Clinical History and Physical Exam An 80 years old man, who had a history of everolimus-eluting stent (EES) implantation in the proximal left anterior descending artery… read more here.

Keywords: tctap 208; appearance peri; 208 appearance; everolimus eluting ... See more keywords